Navigation Links
Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
Date:11/5/2008

SEATTLE, Nov. 5 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that management will present at the following investor conferences in November.

Rodman & Renshaw 10th Annual Healthcare Conference

New York Palace Hotel

Wednesday, November 12, 2008

9:55 a.m. ET

Lazard Capital Markets 5th Annual Healthcare Conference

The St. Regis Hotel, New York

Tuesday, November 18, 2008

8:55 a.m. ET

The presentations will be audio webcast live and available for replay from Dendreon's website, http://www.dendreon.com.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule that targets Trp-p8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist
2. Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
3. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
4. Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
5. Dendreon Reports First Quarter 2008 Financial Results
6. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
7. Dendreon Announces Closing of Registered Direct Offering
8. Dendreon Announces $47 Million Registered Direct Offering
9. Dendreon Reports Fourth Quarter and 2007 Year End Financial Results
10. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
11. -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)...chael R. Drapp, a 34-year veteran of the high-tech...logies, a business development and intellectual pr...nanotechnology space. The company also plans to i...echnology incubator. , Mo... Drapp , a 34-year veteran of the high-technology ...
(Date:11/30/2009)...r 30, 2009 An international team of applied scien...rich have demonstrated compact, multibeam, and mul...t of the light spectrum (infrared). By contrast, t...efined wavelength. The innovative multibeam lasers...ote chemical sensing pollution monitoring, optical...
(Date:11/30/2009)...n., Nov. 30 Acuo Technologies, dev...nt software, data migration tools and services, to...d Clinics for a new Vendor Neutral Archive (VNA), ...he Allina network of hospitals, clinics and affili... Acuo Technologies DICOM Services Grid(TM) Softwar...
(Date:11/30/2009)... Nov. 30 Novavax, Inc. (...announced today that the company will be presentin...n December 2, 2009 at 12:30 pm local time at The N... overview of the company,s business strategy, rese...nes. A link to the live audio only presentation c...
Breaking Biology Technology:Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 2Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 3Silicon Valley Veteran Launches New Venture on the “nanoEdge” of the Emerging Nanotechnology Revolution 4Scientists demonstrate multibeam, multi-functional lasers 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 2Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics 3NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2
... Trial in Medullary Thyroid Cancer Planned to Init...ne 16 ,Exelixis, Inc. (Nasdaq: EXEL ) announced t...dministration (FDA) have reached agreement on the ...ule anticancer compound targeting,MET, RET, and VE... Exelixis,has also discussed the trial design with...
...L, June 14 /PRNewswire-FirstCall/ - ProMetic Life ...ted results on its orally-active,PBI-1402 compound...nduced,anemia ("CIA") at the 13th Congress of the ..., Denmark this week., Dr. Lyne Gagnon, ProMetic,s... in a poster entitled "PBI-1402 increases hemoglob...
...nced Medical Device Executive and Former CFO of Th...ets, Including Non-Invasive Aesthetics, PALO ALTO...f bioabsorbable implants for the fixation of soft ...edicine markets, announced today the,appointment o...ll also,serve as a member of the company,s Board o...
Other Biology Technology:Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 2Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 3Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 4Exelixis Reaches Agreement with FDA on Special Protocol Assessment for XL184 Phase 3 Trial 5Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association 2Positive clinical data for PBI-1402 presented at the Annual Congress of the European Hematology Association 3Coapt Systems New CEO, Laureen DeBuono, to Fuel Company's Growth and Product Innovation 2Coapt Systems New CEO, Laureen DeBuono, to Fuel Company's Growth and Product Innovation 3
(Date:12/1/2009)...al Primate Research Center, Emory University, have...ie voles, an important step toward unlocking the g...ation of this technology will enable scientists to... help identify the brain mechanisms of social bond...cement may also have important implications for un...
(Date:12/1/2009)...rsity cancer researchers have developed a tumor-a...nd blocks the growth of new tumor blood vessels. ,...ill cancer cells oncolytic viruses might be more... also carry a gene for a protein that inhibits blo...atin, is normally produced in the brain. In this s...
(Date:12/1/2009)...Newswire/ -- iQor, a global provider of business p... the 2009 InfoWorld 100 Awards Top 100 IT projec...Q21. This was the first submission for iQor. ,,...igious list of companies," said Vikas Kapoor, pres...orming the way we do business, allowing us to work...
Breaking Biology News(10 mins):Yerkes researchers create first transgenic prairie voles 2Tumor-attacking virus strikes with 'one-two punch' 2iQor Named to InfoWorld 100 List of Top IT Projects of 2009 2Chindex International Inc to Report First Quarter Fiscal 2010 Financial Results 53379 1Chindex International Inc to Report First Quarter Fiscal 2010 Financial Results 53379 2Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 1Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 2Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 3Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 4Advanced Life Sciences Receives Complete Response Letter From FDA for Restanza 28TM 29 28Cethromycin 29 in Community Acquired Pneumonia 13312 5Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 1Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 2Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 3Post Recession Incomes Will Be Hit Hard by Health Care Spending for Middle Class Working Families PENN Analysis Shows 53376 4
... Shakespeare wrote "a rose by any other name,would...at generate its,fragrance were to change their sha...sor of Chemistry at The City,College of New York (...tuart,Firestein, Professor of Biology at Columbia ..., reported today in the journal " Chemistry &,Biol...
...cientists in the United Kingdom are reporting new ...acid (SA) the material formed when aspirin breaks...pirin,s renowned effects in relieving pain and inf...egulators, according to a study scheduled for the ...tural and Food Chemistry . , In the report, Gwend...
...earchers has discovered an entirely new mechanism ...beams. The finding could lead to lasers that opera...n existing devices, and find applications in envir...This discovery provides a new insight into the phy...tudy. Gmachl, an electrical engineer, is the direc...
Other Biology News:Shape changes in aroma-producing molecules determine the fragrances we detect 2Princeton researchers discover new type of laser 2Princeton researchers discover new type of laser 3
... ST-195 allows real-time observations of cell cult...This instrument has 64 different strain parameters...or. The thin silicon strain chamber used by the ST...luorescence microscopy. ST-195 can be used with Ni...
Rabbit Anti-JNK3 / SAPK1b Monoclonal Antibody, Unconjugated, Clone C05T from Upstate
... ViaSure Kit is used in conjunction with the EasyC... automatically. The ViaSure Staining Reagent uses...idine Orange and Ethidium Bromide to identify live...hile the EasyCount Slide 6 Multi-well Slide provi...
...onjugation Kit provides a powerful yet simple tech...tes and nuceleic acids. The kit provides the heter...ents for quantifying conjugation efficiencies. It ...mes, fluorophores, biotin and other tags with a va...
Biology Products: